The UK’s state-run health service said Thursday it will not offer two new treatments for Alzheimer’s disease, citing high costs and “too small” benefits.
Go to Source
https://medicalxpress.com/rss-feed/
Go to Source
https://medicalxpress.com/rss-feed/